Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn’s disease in Europe: a retrospective observational study

Peer Review reports

Original Submission
26 Apr 2023	Submitted	Original manuscript
1 Jul 2023	Reviewed	Reviewer Report
27 Jul 2023	Reviewed	Reviewer Report
5 Oct 2023	Author responded	Author comments - Marc Ferrante
Resubmission - Version 2
5 Oct 2023	Submitted	Manuscript version 2
9 Oct 2023	Reviewed	Reviewer Report
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
6 Nov 2023	Editorially accepted
29 Nov 2023	Article published	10.1186/s12876-023-03032-7

Back to article page